Investing.com -- Coloplast (CSE:COLOB) announced Thursday the appointment of Gavin Wood as its next President and CEO, effective May 1, 2026. The appointment concludes a year-long transition period ...

The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and Chief Executive Officer (CEO) of the Coloplast Group, effective May 1, 2026. Gavin Wood ...

Coloplast delivered Q1 organic growth of 6% and EBIT growth 1 in constant currencies of 3%. Reported revenue in DKK grew 0%, reflecting 4%-points negative impact from currencies. Return on invested ...

Good morning to those of you here in the room, and also good morning to those of you joining us virtually today. On behalf of the Coloplast management team and on behalf of Investor Relations, I would ...

Based in Denmark, Coloplast is a leader in global ostomy and continence care. The firm has made inroads into the concentrated urology and fragmented woundcare markets, but it remains a peripheral ...

Jul. 25—STEWARTVILLE, Minn. — Clearance by the Food and Drug Administration means a Stewartville manufacturer can now sell its fecal incontinence devices in the US, after years of being limited to the ...

Concerns raised over Altis sling as studies show higher rates of pain and complications compared to other mid-urethral slings No reasonable doctor would select this device if they were aware of what ...